Ervebo

Medicinal product

(Invented) name

Ervebo

Active substance (s)

rVSVΔG-ZEBOV-GP (gyvoji)

Strength

72 mln. PFV

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti į raumenis

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J07BX02, ebola virus, live attenuated

Marketing authorisation holder

Merck Sharp & Dohme B.V., Nyderlandai

Date of authorisation

2019-11-11

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Solution for injection	1 ml
rVSVΔG-ZEBOV-GP (gyvoji)	72 mln. PFV

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
102842	88943	1088943	flakonas	N10		Receptinis	EU/1/19/1392/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2019-11-11	Registruotas